MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells

Journal of Pathology

Volumn 223, Issue 4, 2011, Pages 482-495

  Lo, Wen Liang ^a,e   Yu, Cheng Chia ^c,d   Chiou, Guang Yuh ^a,e   Chen, Yi Wei ^a,e   Huang, Pin I ^a,e   Chien, Chian Shiu ^a   Tseng, Ling Ming ^a,e   Chu, Pen Yuan ^a,e   Lu, Kai Hsi ^a,b   Chang, Kuo Wei ^a   Kao, Shou Yen ^a,e   Chiou, Shih Hwa ^a,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

BMI1; cancer stem cells; epithelial mesenchymal transition; head and neck squamous cell carcinoma; metastasis; miR200c

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; BMI1 PROTEIN; HERMES ANTIGEN; LUCIFERASE; MICRORNA; MICRORNA 200C; NERVE CELL ADHESION MOLECULE; PROTEIN; PROTEIN ZEB1; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN;

3' UNTRANSLATED REGION; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CANCER SURVIVAL; CELL INVASION; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SITE DIRECTED MUTAGENESIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; XENOTRANSPLANTATION;

ADULT; AGED; ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIGENS, CD44; CARCINOMA; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; ISOENZYMES; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; MUTAGENESIS, SITE-DIRECTED; NEOPLASM PROTEINS; NEOPLASMS, SQUAMOUS CELL; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RNA, NEOPLASM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79551708071     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2826     Document Type: Article

References (46)

1. Haddad RI, Shin DM,. Recent advances in head and neck cancer. N Engl J Med 2008; 359: 1143-1154.
2. Chen YJ, Chang JT, Liao CT, et al., Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 2008; 99: 1507-1514.
3. Chen YJ, Lin SC, Kao T, et al., Genome-wide profiling of oral squamous cell carcinoma. J Pathol 2004; 204: 326-332. (Pubitemid 39430093)
4. Liu CJ, Liu TY, Kuo LT, et al., Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. J Pathol 2008; 214: 489-497.
5. Rosen JM, Jordan CT,. The increasing complexity of the cancer stem cell paradigm. Science 2009; 324: 1670-1673.
6. Zhou BB, Zhang H, Damelin M, et al., Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009; 8: 806-823.
7. Prince ME, Sivanandan R, Kaczorowski A, et al., Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007; 104: 973-978. (Pubitemid 46154721)
8. Ginestier C, Hur MH, Charafe-Jauffret E, et al., ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567. (Pubitemid 350056407)
9. Ma S, Chan KW, Lee TK, et al., Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008; 6: 1146-1153.
10. Clay MR, Tabor M, Owen JH, et al., Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010; (in press).
11. Huang EH, Hynes MJ, Zhang T, et al., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009; 69: 3382-3389.
12. Chen YC, Chen YW, Hsu HS, et al., Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009; 385: 307-313.
13. Chen YC, Chang CJ, Hsu HS, et al., Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol 2010; 46: 158-165.
14. Molofsky AV, Pardal R, Iwashita T, et al., Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003; 425: 962-967. (Pubitemid 37376927)
15. Park IK, Qian D, Kiel M, et al., Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302-305. (Pubitemid 40852701)
16. Pietersen AM, Evers B, Prasad AA, et al., Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr Biol 2008; 18: 1094-1099.
17. Song LB, Li J, Liao WT, et al., The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009; 119: 3626-3636.
18. Kato M, Slack FJ,. microRNAs: small molecules with big roles-C. elegans to human cancer. Biol Cell 2008; 100: 71-81. (Pubitemid 351266765)
19. Garzon R, Calin GA, Croce CM,. MicroRNAs in cancer. Annu Rev Med 2009; 60: 167-179.
20. Nicoloso MS, Spizzo R, Shimizu M, et al., MicroRNAs - the micro-steering wheel of tumour metastases. Nat Rev Cancer 2009; 9: 293-302.
21. Korpal M, Lee ES, Hu G, et al., The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283: 14910-14914.
22. Shimono Y, Zabala M, Cho RW, et al., Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009; 138: 592-603.
23. Spaderna S, Brabletz T, Opitz OG,. The miR-200 family: central player for gain and loss of the epithelial phenotype. Gastroenterology 2009; 136: 1835-1837.
24. Park SM, Gaur AB, Lengyel E, et al., The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22: 894-907. (Pubitemid 351482843)
25. Nakada C, Matsuura K, Tsukamoto Y, et al., Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 2008; 216: 418-427.
26. Kong D, Li Y, Wang Z, et al., miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 2009; 27: 1712-1721.
27. Shinozaki A, Sakatani T, Ushiku T, et al., Downregulation of microRNA-200 in EBV-associated gastric carcinoma. Cancer Res 2010; (in press).
28. Wiklund ED, Bramsen JB, Hulf T, et al., Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer 2010; (in press).
29. Baffa R, Fassan M, Volinia S, et al., MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009; 219: 214-221.
30. Hurteau GJ, Carlson JA, Spivack SD, et al., Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 2007; 67: 7972-7976. (Pubitemid 47395127)
31. Wellner U, Schubert J, Burk UC, et al., The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11: 1487-1495.
32. Chiou SH, Yu CC, Huang CY, et al., Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008; 14: 4085-4095.
33. Yu CC, Lo WL, Chen YW, et al., Bmi-1 regulates snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1-positive cells. J Oncol 2011; (in press).
34. Wu MJ, Jan CI, Tsay YG, et al., Elimination of head and neck cancer initiating cells through targeting glucose regulated protein 78 signaling. Mol Cancer 2010; 9: 283.
35. Kao CL, Chiou SH, Chen YJ, et al., Increased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous system. Mod Pathol 2005; 18: 769-778.
36. Yang MH, Wu MZ, Chiou SH, et al., Direct regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol 2008; 10: 295-305.
37. Baumann M, Krause M, Hill R,. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 2008; 8: 545-554. (Pubitemid 351881850)
38. Visvader JE, Lindeman GJ,. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755-768.
39. Li J, Huang H, Sun L, et al., MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009; 15: 3998-4008.
40. Wong TS, Liu XB, Wong BY, et al., Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008; 14: 2588-2592.
41. Wong TS, Liu XB, Chung-Wai Ho A, et al., Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 2008; 123: 251-257.
42. Childs G, Fazzari M, Kung G, et al., Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009; 174: 736-745.
43. Liu CJ, Tsai MM, Hung PS, et al., miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 2010; 70: 1635-1644.
44. Chang KW, Liu CJ, Chu TH, et al., Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J Dent Res 2008; 87: 1063-1068.
45. Burk U, Schubert J, Wellner U, et al., A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008; 9: 582-589. (Pubitemid 351772923)
46. Chiou SH, Chen SJ, Chang YL, et al., MafA promotes the reprogramming of placenta-derived multipotent stem cells into pancreatic islets-like and insulin-positive cells. J Cell Mol Med 2010; (in press).